← Back to Influence Map
MARCH-IN Rights Proposal (NIH Framework)
ProposedproposedBiden administration proposed a framework for using march-in rights to address excessive pricing of drugs developed with taxpayer-funded research. PhRMA opposed, calling it government price controls.
Who took a position
Supporting and opposing lists hold cited positions only. Lobbying filings say an entity lobbied on the measure, not which way. Positions the ingest inferred from donations are not positions and are listed separately below as giving to the legislators who voted.
Lobbied on (58)
- NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE
- ASTELLAS PHARMA US, INC.
- PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION
- SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)
- NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
- RUTGERS THE STATE UNIVERSITY OF NEW JERSEY
- HEALTHCARE LEADERSHIP COUNCIL
- UNIVERSITY OF ARIZONA
- AUTM
- COUNCIL FOR INNOVATION PROMOTION (C4IP)
- CONSERVATIVES FOR PROPERTY RIGHTS
- BIOCOM
- and 46 more
Opposing (0)
- No opposing positions recorded.